SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Clinical trials for SYSTEMIC LIGHT CHAIN AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LIGHT CHAIN AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC LIGHT CHAIN AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare amyloidosis: experimental drug targets complete remission
Disease control Recruiting nowThis study tests an experimental drug called TQB2934 in 70 adults with systemic light chain amyloidosis, a rare disease where abnormal proteins build up in organs. The goal is to see if the drug can safely improve the rate of complete remission (disappearance of disease signs) in…
Matched conditions: SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Jun 17, 2026 04:24 UTC
-
Engineered immune cells take aim at rare amyloid disease
Disease control Recruiting nowThis early-phase study tests a personalized cell therapy (CAR-T cells) in 30 adults with relapsed or hard-to-treat light chain amyloidosis, a rare disease where abnormal proteins damage organs. The treatment targets BCMA on harmful plasma cells to reduce protein buildup. The main…
Matched conditions: SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Phase: EARLY_PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New antibody therapy shows promise for rare blood disease
Disease control Recruiting nowThis study tests a new drug called CM336, a bispecific antibody, in 21 people newly diagnosed with a rare disease called AL amyloidosis. The goal is to see if the drug can improve blood markers of the disease and to check for side effects. Participants will receive the drug and b…
Matched conditions: SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC